LTR Pharma Ltd

$0.560

Day Range

$0.550 – $0.600

52 Week Range

$0.270 – $0.810

Volume

0.00

Avg Volume (10D)

1.06M

Market Cap

$101.80M

Price Chart

Market Statistics

Open$0.560

Previous Close$0.560

Day High$0.600

Day Low$0.550

52 Week High$0.810

52 Week Low$0.270

Valuation

Market Cap101.80M

Shares Outstanding181.78M

Price to Book3.99

Trading Activity

Volume0.00

Value Traded0.00

Performance

1 Day-3.28%

5 Day9.26%

13 Week49.37%

52 Week110.71%

YTD-18.06%

Technical Indicators

RSI (14)62.80

50-Day SMA$0.428

200-Day SMA$0.500

The Weekly Finger: On Green and Gold, and Oil and Gold

Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.

By James Whelan··4 min read min read

Biotechnology

LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS

LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.

By Isla Campbell··4 min read min read

Biotechnology

LTR Pharma Unveils Strong SPONTAN Data and Dual US Strategy

LTR Pharma reports SPONTAN PK: 5 mg intranasal Tmax 10 min vs 60 min oral; FDA 505(b)(2) pathway; dual US strategy; $24.1m cash, 2026 milestones

By Isla Campbell··2 min read min read

Biotechnology

LTR Pharma Strengthens SPONTAN Market Readiness With Extended Shelf Life

LTR Pharma (ASX: LTP) has extended the shelf life of its SPONTAN intranasal erectile dysfunction (ED) spray to 18 months, a milestone that strengthens its commercialisation prospects in Australia and key international markets. The achievement, confirmed under International Council for Harmonisation stability conditions, demonstrates both chemical and device reliability across the extended period. It positions […]

By Nik Hill··2 min read min read